[
  {
    "ts": "2026-01-30T07:51:00+00:00",
    "headline": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC",
    "summary": "The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at billions of dollars.",
    "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
      "content": {
        "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
        "contentType": "STORY",
        "title": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC",
        "description": "",
        "summary": "The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at billions of dollars.",
        "pubDate": "2026-01-30T07:51:00Z",
        "displayTime": "2026-01-30T07:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/99c64a7e-e4a1-347d-9ef5-be0276d3ad99/astrazeneca-strikes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dguVajvjbuUaLrMArJPZcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/77NLSWy3dAWrjld75.ROMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ZLDPF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T07:53:16+00:00",
    "headline": "Novo Obesity Pill Spurs Rally After Stock’s Worst Ever Year",
    "summary": "Novo started selling its Wegovy pill a few weeks ago, beating rival Eli Lilly & Co. to market and boosting sentiment after a string of bad news pummeled the shares last year.  “2026 will be a transition year,” said Robert Hannaford, deputy portfolio manager of the Evenlode Global Income fund, adding that the pill launch seems to be going well.  Analysts at Goldman Sachs Group Inc. agree.",
    "url": "https://finance.yahoo.com/news/novo-obesity-pill-spurs-rally-075316463.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "794b7885-4020-3136-9705-b0f484353dc0",
      "content": {
        "id": "794b7885-4020-3136-9705-b0f484353dc0",
        "contentType": "STORY",
        "title": "Novo Obesity Pill Spurs Rally After Stock’s Worst Ever Year",
        "description": "",
        "summary": "Novo started selling its Wegovy pill a few weeks ago, beating rival Eli Lilly & Co. to market and boosting sentiment after a string of bad news pummeled the shares last year.  “2026 will be a transition year,” said Robert Hannaford, deputy portfolio manager of the Evenlode Global Income fund, adding that the pill launch seems to be going well.  Analysts at Goldman Sachs Group Inc. agree.",
        "pubDate": "2026-01-30T07:53:16Z",
        "displayTime": "2026-01-30T07:53:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/2164d05c7499cf462198bd47d9de765b",
          "originalWidth": 2000,
          "originalHeight": 1334,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1QKsVlWVK1M7vV.bEXiHIw--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/2164d05c7499cf462198bd47d9de765b.cf.webp",
              "width": 2000,
              "height": 1334,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/18J.sIWZuXOPWxjucHiCJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/2164d05c7499cf462198bd47d9de765b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-obesity-pill-spurs-rally-075316463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-obesity-pill-spurs-rally-075316463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T10:53:57+00:00",
    "headline": "Repertoire and Lilly join hands on autoimmune disease therapies",
    "summary": "The agreement grants Repertoire an upfront payment of $85m, with the possibility of up to $1.84bn in additional milestone payments.",
    "url": "https://www.hospitalmanagement.net/news/repertoire-lilly-autoimmune-disease-therapies/",
    "source": "Hospital Management",
    "provider": "yfinance",
    "raw": {
      "id": "c9746782-0772-3c42-ae5b-0f84ef2ee569",
      "content": {
        "id": "c9746782-0772-3c42-ae5b-0f84ef2ee569",
        "contentType": "STORY",
        "title": "Repertoire and Lilly join hands on autoimmune disease therapies",
        "description": "",
        "summary": "The agreement grants Repertoire an upfront payment of $85m, with the possibility of up to $1.84bn in additional milestone payments.",
        "pubDate": "2026-01-30T10:53:57Z",
        "displayTime": "2026-01-30T10:53:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/hospital_management_177/ee99b00a6dd1295612114ac3cb6562d4",
          "originalWidth": 1440,
          "originalHeight": 820,
          "caption": "Lilly will oversee clinical development",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KXwu0PC72.9xQjai55982w--~B/aD04MjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/hospital_management_177/ee99b00a6dd1295612114ac3cb6562d4.cf.webp",
              "width": 1440,
              "height": 820,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/47VNH4OjLT1lOhT2dUKsTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/hospital_management_177/ee99b00a6dd1295612114ac3cb6562d4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Hospital Management",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.hospitalmanagement.net/news/repertoire-lilly-autoimmune-disease-therapies/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/repertoire-lilly-join-hands-autoimmune-105357068.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]